TABLE 3.
Expression levels of serum inflammatory cytokines and lymphocyte subsets between MPP group and NMPP group.
| MPP(n = 265) | NMPP(n = 230) | T(Z)or χ2 | P value | |
|---|---|---|---|---|
| IL‐6 (pg/mL) | 7.5(3.8,17.0) | 4.9(2.7,10.8) | −4.7 | <0.001 |
| IL‐8 (pg/mL) | 39.0(17.7,100.0) | 33.6(16.5,69.6) | −2.5 | 0.01 |
| IL‐10 (pg/mL) | 5.7(5.0,13.6) | 5.0(3.3,9.0) | −4.1 | <0.001 |
| IL‐1β (pg/mL) | 11.2(5.3,19.0) | 8.2(4.4,14.8) | −4.0 | <0.001 |
| sIL‐2R (U/mL) | 970.0(734.0,1257.0) | 910.50(705.0,1187.0) | −1.5 | 0.14 |
| TNF‐α (pg/mL) | 17.8(12.4,27.4) | 16.8(11.5,23.2) | −1.9 | 0.06 |
| CD3+ (%) | 69.2(63.2,73.9) | 65.9(60.0,71.1) | −3.5 | <0.001 |
| CD4+ (%) | 36.9 ± 7.7 | 35.7 ± 8.8 | 3.0 | 0.09 |
| CD8+ (%) | 24.3 ± 6.60 | 23.7 ± 6.9 | 1.0 | 0.32 |
| CD4+/CD8+ (%) | 1.6 ± 0.6 | 1.7 ± 0.7 | 7.0 | 0.01 |
| CD16+CD56+NK cell (%) | 8.7(5.8,13.1) | 9.06(5.3,13.2) | −0.2 | 0.9 |
|
CD19+ (%) |
20.2 ± 7.7 | 23.1 ± 9.4 | 6.8 | 0.01 |
Notes: The data were the baseline measurement data made within 24 h after admission. P < 0.05 indicates statistical significance.
Abbreviations: IL‐10, interleukin‐10; IL‐1β, interleukin‐1β; IL‐6, interleukin‐6; IL‐8, interleukin‐8; sIL‐2R, soluble interleukin‐2 receptor; TNF‐α, tumour necrosis factor‐α.